The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.
Fleming Researcher Prof. George Kollias has been awarded the first Galien Scientific Research Award at the Prix Galien Greece 2015. The prize recognizes his seminal contributions towards the development of biological therapies for rheumatoid arthritis and the discovery of novel disease pathways in animal models of chronic inflammation and autoimmunity. (Press release in Greek)
Papanikolopoulou & Skoulakis demonstrate that Tau-mediated neuronal dysfunction and toxicity are separable and in fact neuronal dysfunction, which requires phosphorylation on Ser262, precedes and is required for Ser238 phosphorylation which in turn is requisite for premature lethality. PubMed
Dr Antigone Dimas, Marie-Curie and EMBO Research Fellow at BSRC Alexander Fleming, was awarded this year’s L’Oréal-UNESCO Award for Women in Science. This prestigious award rewards promising young women scientists whose outstanding achievements have contributed to the advancement of scientific knowledge.
Seminar 04/09/2015, 13.00. "Lgr5 Stem Cells and Organoids", Marc van de Wetering, Ph.D, Hubrecht Institute Clevers group & Hubrecht Organoid Technology, Utrecht, The Netherlands.
Seminar 07/07/2015, 14.00. "Regardless of size they play a big role – Noncoding RNAs in fibrosis", Naftali Kaminski, Ph.D, Boehringer-Ingelheim Endowed Professor of Internal Medicine, Chief of Pulmonary, Critical Care and Sleep Medicine Yale School of Medicine.